JP2005522210A5 - - Google Patents

Download PDF

Info

Publication number
JP2005522210A5
JP2005522210A5 JP2003583334A JP2003583334A JP2005522210A5 JP 2005522210 A5 JP2005522210 A5 JP 2005522210A5 JP 2003583334 A JP2003583334 A JP 2003583334A JP 2003583334 A JP2003583334 A JP 2003583334A JP 2005522210 A5 JP2005522210 A5 JP 2005522210A5
Authority
JP
Japan
Prior art keywords
polypeptide
fusion protein
biological sample
antigen
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2003583334A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005522210A (ja
Filing date
Publication date
Priority claimed from US10/121,988 external-priority patent/US20030068327A1/en
Priority claimed from US10/200,562 external-priority patent/US20030165819A1/en
Priority claimed from US10/237,551 external-priority patent/US6821519B2/en
Application filed filed Critical
Publication of JP2005522210A publication Critical patent/JP2005522210A/ja
Publication of JP2005522210A5 publication Critical patent/JP2005522210A5/ja
Withdrawn legal-status Critical Current

Links

JP2003583334A 2002-04-11 2003-04-09 単純ヘルペスウイルス感染の診断および処置に対する組成物および方法 Withdrawn JP2005522210A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/121,988 US20030068327A1 (en) 2000-06-29 2002-04-11 Compositions and methods for the diagnosis and threatment of herpes simplex virus infection
US10/200,562 US20030165819A1 (en) 2000-06-29 2002-07-19 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
US10/237,551 US6821519B2 (en) 2000-06-29 2002-09-06 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
PCT/US2003/011231 WO2003086308A2 (en) 2002-04-11 2003-04-09 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection

Publications (2)

Publication Number Publication Date
JP2005522210A JP2005522210A (ja) 2005-07-28
JP2005522210A5 true JP2005522210A5 (cg-RX-API-DMAC7.html) 2006-06-29

Family

ID=29255203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003583334A Withdrawn JP2005522210A (ja) 2002-04-11 2003-04-09 単純ヘルペスウイルス感染の診断および処置に対する組成物および方法

Country Status (6)

Country Link
US (1) US6821519B2 (cg-RX-API-DMAC7.html)
EP (1) EP1492563A4 (cg-RX-API-DMAC7.html)
JP (1) JP2005522210A (cg-RX-API-DMAC7.html)
AU (1) AU2003221897A1 (cg-RX-API-DMAC7.html)
CA (1) CA2481087A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003086308A2 (cg-RX-API-DMAC7.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1348463A (zh) 1998-08-07 2002-05-08 华盛顿大学 免疫学单纯疱疹病毒抗原及其使用方法
US6507042B1 (en) * 1998-12-25 2003-01-14 Fujitsu Limited Semiconductor device and method of manufacturing the same
AU2001289813B2 (en) * 2000-08-17 2005-07-28 Intercell Ag A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof
CA2454750C (en) * 2001-07-31 2012-09-18 David M. Koelle Immunologically significant herpes simplex virus antigens and methods for using same
DE60324678D1 (de) 2002-07-18 2008-12-24 Univ Washington N t-lymphozyten und damit identifizierte hsv-antigene
US7267940B2 (en) * 2003-03-04 2007-09-11 Bio-Rad Laboratories, Inc. HSV-2 type-specific immunoassays using glycoprotein G2 peptides
WO2004091491A2 (en) * 2003-04-10 2004-10-28 Transform Pharmaceuticals, Inc. Profiling conformational variants, antibody compositions and methods of using the same
EP2267166B1 (en) * 2003-04-25 2016-01-13 Becton Dickinson and Company Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
US8541002B2 (en) * 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
US7638318B2 (en) * 2003-09-26 2009-12-29 Norvartis Ag Seneca Valley virus based compositions and methods for treating disease
JP2007526919A (ja) * 2004-03-05 2007-09-20 バイオ−ラッド ラボラトリーズ,インコーポレイティド 糖タンパク質g2ペプチドを用いたhsv−2型特異的免疫検定
WO2006133099A2 (en) * 2005-06-03 2006-12-14 The Cbr Institute For Biomedical Research, Inc. Sirna microbicides for preventing and treating viral diseases
US7763460B2 (en) 2005-06-24 2010-07-27 Focus Diagnostics, Inc. Methods and compositions for detecting herpes simplex virus type 2
US7628993B2 (en) 2006-07-20 2009-12-08 Vical Incorporated Compositions and methods for vaccinating against HSV-2
US8865185B2 (en) 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
EP2059255A4 (en) 2006-09-08 2011-08-31 Univ Pennsylvania HSV-1 AND HSV-2 VACCINES AND METHOD FOR THEIR USE
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US9284355B2 (en) 2006-12-28 2016-03-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US8460674B2 (en) * 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
EP2413950A4 (en) 2009-04-03 2013-05-01 Univ Washington ANTIGENIC HSV-2 PEPTIDE AND METHOD OF USE THEREOF
RU2585961C9 (ru) 2009-05-22 2016-12-27 Дженосеа Биосайенсиз Инк. Вакцины против вируса простого герпеса 2 типа: композиции и способы запуска иммунного ответа
JP6055776B2 (ja) * 2010-11-24 2016-12-27 ジェノセア バイオサイエンシーズ, インコーポレイテッド 単純ヘルペスウイルス2型に対するワクチン:免疫応答を誘発する組成物及び方法
BR112014008167B1 (pt) 2011-10-05 2022-05-24 Genvec Inc Adenovírus ou vetor adenoviral e composição os compreendendo
CA2851251C (en) 2011-10-05 2023-09-12 Genvec, Inc. Simian (gorilla) adenovirus or adenoviral vectors and methods of use
CA2850627C (en) 2011-10-05 2024-05-21 Genvec, Inc. Affenadenovirus (gorilla) or adenoviral vectors and methods of use
JP6199878B2 (ja) 2011-11-23 2017-09-20 ジェノセア バイオサイエンシーズ, インコーポレイテッド 単純ヘルペスウイルス2型に対する核酸ワクチン:免疫応答を誘発する組成物及び方法
SMT201800368T1 (it) 2012-05-16 2018-09-13 Immune Design Corp Vaccini per l'infezione da virus-2 herpes simplex
EP2855511B1 (en) * 2012-05-29 2019-07-24 GenVec, Inc. Herpes simplex virus vaccine
EP3519427A4 (en) 2016-09-28 2020-03-11 Genocea Biosciences Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF HERPES
KR101962683B1 (ko) * 2016-09-28 2019-03-27 주식회사 에스엘백시젠 Hsv-2 감염 예방 및 치료용 dna 백신
WO2018186755A1 (en) * 2017-04-04 2018-10-11 Beagley Kenneth Novel vaccine for the prevention or treatment of an infection caused by a herpes virus.
CN109701008B (zh) * 2019-02-18 2022-06-21 山东兴瑞生物科技有限公司 针对单纯疱疹病毒的治疗性dc复合疫苗及其制备方法
EP3999093A4 (en) 2019-07-19 2023-11-22 Merck Sharp & Dohme LLC ANTIGENIC E GLYCOPROTEIN POLYPEPTIDES, COMPOSITIONS AND METHODS OF USE THEREOF
MX2022000879A (es) * 2019-07-21 2022-05-02 Glaxosmithkline Biologicals Sa Vacuna viral terapeutica.
WO2025153100A1 (en) * 2024-01-19 2025-07-24 Sichuan Clover Biopharmaceuticals, Inc. Herpes simplex virus recombinant antigen and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232710B (cg-RX-API-DMAC7.html) 1991-09-13 1994-10-21 American Cyanamid Co
KR100310510B1 (ko) * 1993-03-23 2002-07-04 장 스테판느 3-0-탈아세틸화모노포스포릴지질a를함유하는백신조성물
US6197497B1 (en) * 1995-04-21 2001-03-06 University Of New Mexico Immunoassay for herpes simplex virus
AT404838B (de) 1995-11-24 1999-03-25 Immuno Ag Herstellung von proteinen aus pro-proteinen durch fusionsproteine abgeleitet von furin oder furinanalogen
CA2270282A1 (en) * 1996-11-04 1998-05-14 Smithkline Beecham Corporation Novel coding sequences from herpes simplex virus type-2
US6022847A (en) * 1997-03-19 2000-02-08 Zymogenetics, Inc. Secreted salivary zsig32 polypeptides
CA2291010A1 (en) 1997-06-02 1998-12-10 Chiron Corporation Herpes simplex virus vp22 vaccines and methods of use
JP2002517261A (ja) 1998-06-10 2002-06-18 スミスクライン・ビーチャム・コーポレイション 単純ヘルペスウイルス性起点結合蛋白−n−末端切断(obp−nt)
CN1348463A (zh) 1998-08-07 2002-05-08 华盛顿大学 免疫学单纯疱疹病毒抗原及其使用方法
JP2003512305A (ja) 1999-09-30 2003-04-02 ユニバーシティ オブ ワシントン 免疫学的に重要な単純疱疹ウイルス抗原

Similar Documents

Publication Publication Date Title
FI106317B (fi) Hepatiitti-C-viruksen (HCV) antigeeniyhdistelmät käytettäväksi anti-HCV-vasta-aineiden immunomäärityksissä
ES2650395T3 (es) Kits de diagnóstico y métodos de inmunoensayo para el diagnóstico y la diferenciación de virus de la fiebre porcina africana (ASFV) y virus de la fiebre porcina clásica (CSFV)
JPS6180048A (ja) 重抗原のための螢光偏光イムノアツセイ
JP2005504513A5 (cg-RX-API-DMAC7.html)
Roggendorf et al. Comparison of solid phase test systems for demonstrating antibodies against hepatitis A virus (anti‐HAV) of the IgM‐class
US5645983A (en) Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same
JPH07503614A (ja) Hcv蛋白のための哺乳動物発現システム
JP2004512824A5 (cg-RX-API-DMAC7.html)
JP2001505778A (ja) HIV感染の初期の検出のための未変性の(non―dentured)HIV抗原を使用する新規のEIA試験
Bolognesi et al. Immunological properties of avian oncornavirus polypeptides
CN115176162B (zh) 新型冠状病毒抗原及其检测用途
JPS62249999A (ja) 非a非b型ウイルス性肝炎検出用試薬および免疫酵素法による前記肝炎の診断法
JPS60501241A (ja) ウイルス抗原、その製法および診断と治療(ワクチン)におけるその使用
US20130337434A1 (en) Method of Preparing Magnetic Bead Type Nasopharyngeal Enzyme Immunoassay Reagents by Polymerase Chain Reaction
CN110996986B (zh) Hcv抗原的多表位融合蛋白及其用途
WO2003040186A1 (en) Monoclonal antibody against canine distemper virus and method of diagnosis of distemper
CN108948153B (zh) 一种瓜氨酸修饰肽抗原组合及其应用
US20090280474A1 (en) Method for detecting a virus
CN101781360B (zh) 一种重组风疹病毒蛋白及应用
JPH0940694A (ja) 肝炎gbウイルスの合成ペプチド及びその使用
CN108948173B (zh) 一种瓜氨酸修饰肽及其应用
Sánchez-Vizcaíno African swine fever diagnosis
CN109470855B (zh) 肺癌早期诊断用蛋白芯片及试剂盒
ES2257095T3 (es) Especificidad mejorada en la deteccion de anticuerpos igm de anti-rubeola.
CN114910649A (zh) 检测抗α-烯醇化酶-IgG抗体的试剂在制备检测血管内皮损伤的试剂盒中的应用